Knights of Columbus Asset Advisors’s Emergent Biosolutions EBS Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-30,661	Closed	-$2.85M	–	314
2021 Q1	$2.85M	Buy	30,661 +3,657	+14%	+$375K	0.28%	119
2020 Q4	$2.42M	Buy	27,004 +8	+0%	+$734	0.26%	140
2020 Q3	$2.79M	Sell	26,996 -8,821	-25%	-$951K	0.35%	102
2020 Q2	$2.83M	Sell	35,817 -11,514	-24%	-$858K	0.35%	93
2020 Q1	$2.74M	Sell	47,331 -9,672	-17%	-$557K	0.35%	82
2019 Q4	$3.08M	Buy	+57,003	New	+$3.09M	0.27%	109

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Knights of Columbus Asset Advisors's EBS Position: Q2 2021 in Review

Knights of Columbus Asset Advisors sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 30,661 shares — an estimated $2.85M sold.

Knights of Columbus Asset Advisors first reported a position in EBS in Q4 2019 and held it in 6 quarters. The position peaked at $3.08M in Q4 2019. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

Knights of Columbus Asset Advisors reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
Knights of Columbus Asset Advisors sold 30,661 Emergent Biosolutions shares in Q2 2021, an estimated $2.85M.
Knights of Columbus Asset Advisors first reported a position in Emergent Biosolutions in Q4 2019 and held it in 6 quarters.
Knights of Columbus Asset Advisors's Emergent Biosolutions position peaked at $3.08M in Q4 2019.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.